Unlock Premium for Just $9.99/Month – Special Launch Offer, Limited Time Only Get Premium

LFCR Lifecore Biomedical Inc

Price (delayed)

$6.89

Market cap

$255.1M

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$1.48

Enterprise value

$379.1M

Landec Corporation is a leading innovator of diversified health and wellness solutions with two operating businesses: Curation Foods, Inc. and Lifecore Biomedical, Inc.Landec designs, develops, manufactures and sells products for ...

Highlights
The company's quick ratio rose by 39% YoY and by 16% QoQ
LFCR's revenue is up by 7% YoY
Lifecore Biomedical's gross profit has increased by 35% YoY but it has decreased by 4.5% QoQ
The company's gross margin rose by 26% YoY but it fell by 4.3% QoQ
LFCR's EPS has shrunk by 196% QoQ and by 121% YoY
Lifecore Biomedical's net income has plunged by 121% YoY

Key stats

What are the main financial stats of LFCR
Market
Shares outstanding
37.03M
Market cap
$255.1M
Enterprise value
$379.1M
Valuations
Price to earnings (P/E)
N/A
Price to book (P/B)
114.45
Price to sales (P/S)
1.96
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
2.91
Earnings
Revenue
$130.31M
Gross profit
$43.59M
Operating income
-$20.42M
Net income
-$44.65M
EBIT
-$22.6M
EBITDA
-$14.23M
Free cash flow
-$3.87M
Per share
EPS
-$1.48
EPS diluted
-$1.45
Free cash flow per share
-$0.1
Book value per share
$0.06
Revenue per share
$3.52
TBVPS
$5.93
Balance sheet
Total assets
$237.69M
Total liabilities
$190.27M
Debt
$129.41M
Equity
$2.23M
Working capital
$53.1M
Liquidity
Debt to equity
58.06
Current ratio
2.71
Quick ratio
1.31
Net debt/EBITDA
-8.71
Margins
EBITDA margin
-10.9%
Gross margin
33.4%
Net margin
-34.3%
Operating margin
-15.7%
Efficiency
Return on assets
-19.9%
Return on equity
-788.6%
Return on invested capital
-7.1%
Return on capital employed
-10.9%
Return on sales
-17.3%
Dividend
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A

LFCR stock price

How has the Lifecore Biomedical stock price performed over time
Intraday
-1.57%
1 week
0.88%
1 month
32.25%
1 year
3.61%
YTD
-7.27%
QTD
-2.13%

Financial performance

How have Lifecore Biomedical's revenue and profit performed over time
Revenue
$130.31M
Gross profit
$43.59M
Operating income
-$20.42M
Net income
-$44.65M
Gross margin
33.4%
Net margin
-34.3%
Lifecore Biomedical's net income has plunged by 121% YoY
Lifecore Biomedical's net margin has plunged by 107% YoY
LFCR's operating margin has plunged by 67% from the previous quarter and by 8% YoY
The company's operating income has shrunk by 66% QoQ and by 16% YoY

Price vs fundamentals

How does LFCR's price correlate with its fundamentals

Growth

What is Lifecore Biomedical's growth rate over time

Valuation

What is Lifecore Biomedical stock price valuation
P/E
N/A
P/B
114.45
P/S
1.96
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
2.91
LFCR's EPS has shrunk by 196% QoQ and by 121% YoY
LFCR's equity has dropped by 87% year-on-year and by 86% since the previous quarter
The price to sales (P/S) is 23% higher than the last 4 quarters average of 1.6 but 22% lower than the 5-year quarterly average of 2.5
LFCR's revenue is up by 7% YoY

Efficiency

How efficient is Lifecore Biomedical business performance
The ROA has plunged by 146% YoY
Lifecore Biomedical's ROE has soared by 87% YoY

Dividends

What is LFCR's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for LFCR.

Financial health

How did Lifecore Biomedical financials performed over time
LFCR's total assets is 25% more than its total liabilities
The company's quick ratio rose by 39% YoY and by 16% QoQ
The company's current ratio rose by 31% YoY and by 17% QoQ
LFCR's equity has dropped by 87% year-on-year and by 86% since the previous quarter
Lifecore Biomedical's debt has increased by 2.5% YoY

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.